Variations in the APP gene promoter region and risk of Alzheimer disease

Neurology. 2007 Feb 27;68(9):684-7. doi: 10.1212/01.wnl.0000255938.33739.46.

Abstract

We genotyped five polymorphisms, including two polymorphisms with known effects on transcriptional activity, in a large cohort of 427 Alzheimer disease (AD) cases and 472 control subjects. An association between rs463946 (-3102 G/C) and AD was found and was confirmed in a replication sample of a similar size. By contrast, analysis of three recently described rare mutations influencing APP transcription did not confirm their association with AD risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics*
  • Amyloid beta-Protein Precursor / genetics*
  • Biomarkers, Tumor / genetics
  • DNA Mutational Analysis / methods
  • Female
  • France / epidemiology
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics
  • Genetic Testing / methods*
  • Genetic Variation / genetics*
  • Heterozygote
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics*
  • Promoter Regions, Genetic
  • Protease Nexins
  • Receptors, Cell Surface / genetics*
  • Risk Assessment / methods*
  • Risk Factors

Substances

  • APP protein, human
  • Amyloid beta-Protein Precursor
  • Biomarkers, Tumor
  • Protease Nexins
  • Receptors, Cell Surface